Diagnosis of early gastric cancer

Forskningsoutput: Patent


The present invention pertains to a method for determination of the significance of a histologically detected premalignant lesion as a risk for intestinal type gastric cancer or carcinoma in situ, comprising detecting from a patient sample comprising gastric mucosa cells a) cyclooxygenase-2 Cox-2) mRNA expression, or b) Cox-2 protein; wherein overexpression of Cox-2 is indicative of an increased risk for intestinal type gastric cancer.
Utgivningsår9 jul 2002
StatusPublicerad - 9 jul 2002
MoE-publikationstypH1 Beviljat patent


  • 312 Klinisk medicin

Citera det här